Ligand Pharmaceuticals Inc (LGND)
EBITDA
$72.52M
Quarterly · Period ending: · USD
LGND EBITDA
Latest reported$72.52Mperiod ending
Latest reported$72.52Mperiod ending
LGND Quarterly EBITDA (-$5.20M → $72.52M)
Quarterly EBITDA
High-resolution chart · PNG
LGND ebitda history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA (USD) |
|---|---|
| 72,519,000 | |
| -14,296,000 | |
| 66,404,000 | |
| 149,406,000 | |
| 20,898,000 | |
| -40,543,000 | |
| -29,690,000 | |
| 3,396,000 | |
| -55,269,000 | |
| 122,353,000 | |
| 26,658,000 | |
| -3,532,000 | |
| 12,950,000 | |
| 65,343,000 | |
| 66,240,000 | |
| 26,191,000 | |
| 23,750,000 | |
| 6,779,000 | |
| 7,083,000 | |
| 24,519,000 | |
| 23,931,000 | |
| 24,688,000 | |
| 22,576,000 | |
| -795,000 | |
| 38,554,000 | |
| -15,487,000 | |
| 22,695,000 | |
| -2,334,000 | |
| -2,143,000 | |
| 856,705,000 | |
| -33,349,000 | |
| 96,151,000 | |
| 73,186,000 | |
| 61,195,000 | |
| 37,573,000 | |
| 17,599,000 | |
| 14,226,000 | |
| 13,195,000 | |
| 22,492,000 | |
| 8,400,000 | |
| 6,782,000 | |
| 17,671,000 | |
| 11,937,000 | |
| 9,586,000 | |
| 5,229,000 | |
| 4,222,000 | |
| 10,858,000 | |
| 4,375,000 | |
| 2,163,000 | |
| 5,972,000 | |
| 7,282,000 | |
| 3,965,000 | |
| 2,707,000 | |
| 4,691,000 | |
| 5,297,000 | |
| -623,000 | |
| -1,730,000 | |
| -74,000 | |
| 7,403,000 | |
| -3,399,000 | |
| -467,000 | |
| -2,218,000 | |
| -4,059,000 | |
| -15,675,000 | |
| -2,807,000 | |
| -4,026,000 | |
| 1,047,000 | |
| 1,857,000 | |
| -3,664,000 | |
| -6,469,000 | |
| -70,223,000 | |
| -5,443,000 | |
| -5,633,000 | |
| -11,899,000 | |
| -7,678,000 | |
| -8,325,000 | |
| -13,428,000 | |
| -28,129,000 | |
| 7,582,000 | |
| -18,283,000 | |
| -13,425,000 | |
| -9,587,000 | |
| 4,098,000 | |
| 158,000 | |
| -1,783,000 | |
| -11,311,000 | |
| -24,281,000 | |
| -11,736,000 | |
| -15,476,000 | |
| -15,273,000 | |
| 14,232,000 | |
| -4,663,000 | |
| -5,530,000 | |
| -8,936,000 | |
| -4,209,000 | |
| -5,014,000 | |
| -7,756,000 | |
| -723,000 | |
| -1,216,000 | |
| -2,849,000 |